Peptide Association

Insights

NewsBlog
Start free intake

DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

The compound database

Peptide Database

264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.

FDA-approved
90
FDA-approved
Awaiting FDA
8
Awaiting FDA
No lawful pathway
166
No lawful pathway
1–7 of 7 · PerformanceClear filters
  1. 001

    Melanotan II

    A synthetic cyclic analog of alpha-melanocyte stimulating hormone (alpha-MSH) that non-selectively activates melanocortin receptors. Through MC1R it stimulates…

    Performance · Investigational · Subcutaneous injection

    No lawful pathway
  2. 002

    IGF-1 LR3 (Long-Arg3)

    IGF-1 LR3 is a synthetic analogue of insulin-like growth factor 1 with a 13-amino-acid N-terminal extension and arginine substituted for glutamate at position…

    Performance · Research Phase · Subcutaneous injection

    No lawful pathway
  3. 003

    IGF-1 DES (1-3)

    IGF-1 DES (1-3) is a truncated form of insulin-like growth factor 1 lacking the first three N-terminal residues, glycine-proline-glutamate, and it occurs…

    Performance · Research Phase · Subcutaneous injection

    No lawful pathway
  4. 004

    MGF (Mechano Growth Factor)

    Mechano Growth Factor is the name given to a splice variant of the IGF-1 gene, IGF-1Eb in rodents and IGF-1Ec in humans, that is upregulated in muscle after…

    Performance · Research Phase · Intramuscular injection

    No lawful pathway
  5. 005

    PEG-MGF

    PEG-MGF is described by its vendors as a pegylated derivative of Mechano Growth Factor, with polyethylene glycol added in the expectation that it slows renal…

    Performance · Research Phase · Subcutaneous injection

    No lawful pathway
  6. 006

    Follistatin-344

    Follistatin-344 is an alternatively spliced isoform of follistatin, a secreted binding protein that neutralizes myostatin, activin and other TGF-beta…

    Performance · Investigational · Intramuscular injection, Gene delivery

    No lawful pathway
  7. 007

    ACE-031 (Ramatercept)

    ACE-031 is a recombinant fusion protein combining the extracellular domain of activin receptor type IIB with a human IgG1 Fc domain. The soluble receptor acts…

    Performance · Investigational · Subcutaneous injection

    No lawful pathway

Index · all 264 peptides, A–Z

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.